Quarterly report pursuant to Section 13 or 15(d)

Restatement of Condensed Consolidated Financial Statements (Tables)

v3.22.1
Restatement of Condensed Consolidated Financial Statements (Tables)
3 Months Ended
Jun. 30, 2021
Accounting Changes and Error Corrections [Abstract]  
Summary of Restatement Impact
Three months ended June 30, 2021
Reported Adjustment Restated
Net revenues $ 212,615 $ (54,540) $ 158,075
Costs of revenues and operating expenses
License fees and revenue share 138,348 (54,540) 83,808
Other direct costs of revenues 2,533 1,935 4,468
Product development 15,547 (2,623) 12,924
Sales and marketing 13,736 13,736
General and administrative 23,296 688 23,984
Restructuring and impairment costs 10 10
Total costs of revenues and operating expenses 193,470 138,930
Income from operations $ 19,145 $ 19,145